Joseph McMahon

Vestaron Corp. develops and markets bioinsecticides derived from naturally occurring peptides. It offers the following brands: Spear-T for the treatment of thrips, Spear-P controls Colorado Potato beetle, and Spear-C protects crops from lepidopteran pests. The company was founded by Glenn F. King in 2005 and is headquartered in Durham, NC.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia.

Ultivue, Inc. engages in provision of biotechnology services. It offers super-resolution imaging, single-molecule and diagnostics services. Its product Multiplex IHC Reagent Kits, a performance marker multiplexing detection and analysis.The company was founded by Peng Yin, David Walt and Ralf Jumgmann in 2015 and is headquartered in Cambridge, MA.

Kytopen Corp. engages in the provision of technology solutions. It develops genetically engineered cells that modifies microorganisms. The company was founded by Paulo A. Gracia and Cullen R. Buie in 2017 and is headquartered in Cambridge, MA.

Inflammatix, Inc. operates molecular diagnostics company which develops rapid tests that read the immune system. The firm specializes in molecular diagnostics, biotechnology, computational immunology, in-vitro diagnostics, personalized medicine and bioinformatics. The company was founded by Purvesh Khatri, Jonathan Romanowsky and Timothy Sweeney and is headquartered in Burlingame, CA.

Northpond Ventures LLC (Northpond Ventures) is a venture capital firm founded in 2018 by Sharon Kedar and Michael Pinchas Rubin. The firm is headquartered in Maryland.

Slingshot Biosciences, Inc. is a life sciences company that develops synthetic cells for various applications in diagnostics and therapeutics. The company is based in Emeryville, CA. The company utilizes advances in distributed manufacturing, engineering, and polymer chemistry to provide an industry-first, off-the-shelf solution for cell-like reagents that are stable, low-cost, and targeted towards a range of indications and markets. Slingshot Biosciences focuses on developing cutting-edge tools for fluorescence imaging to revolutionize how scientists explore and understand the intricate mechanisms of life. The company is committed to empowering researchers with exceptional products that enable groundbreaking discoveries and shape the future of bioscience. The company was founded in 2012 by Jeffrey Kim, who has been the CEO since 2012.

Torus Biosystems, Inc. engages in the provision of biotechnology services. It performs DNA testing for scientific and medical research purposes. The company was founded in 2019 and is headquartered in Brookline, MA.

inSoma Bio, Inc. operates as a biotechnology company. It engages in the creation of biomaterials to solve problems in tissue engineering and regenerative medicine. The company was founded by Stefan E. Roberts, Ashutosh Chilkoti, and Scott Hollenbeck in 2018 and is headquartered in Durham, NC.

Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.

EnPlusOne Biosciences, Inc is a company that develops an enzymatic synthesis platform to unlock site-specific and diverse RNA modification. The company is based in Watertown, MA. The company was founded by Dan Ahlstedt, George Church, Howon Lee, Daniel Wiegand, Jonathan Rittichier. Daniel Wiegand has been the CEO since incorporation.